Geode Capital Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
40,412
+19,035
| +89% | +$132K | ﹤0.01% | 3762 |
|
|
2025
Q1 | $181K | Sell |
21,377
-17,438
| -45% | -$148K | ﹤0.01% | 3877 |
|
|
2024
Q4 | $543K | Buy |
38,815
+480
| +1% | +$6.72K | ﹤0.01% | 3573 |
|
|
2024
Q3 | $868K | Buy |
38,335
+16,958
| +79% | +$384K | ﹤0.01% | 3405 |
|
|
2024
Q2 | $433K | Hold |
21,377
| – | – | ﹤0.01% | 3619 |
|
|
2024
Q1 | $532K | Buy |
21,377
+2,540
| +13% | +$63.2K | ﹤0.01% | 3591 |
|
|
2023
Q4 | $341K | Buy |
18,837
+1,693
| +10% | +$30.6K | ﹤0.01% | 3748 |
|
|
2023
Q3 | $344K | Hold |
17,144
| – | – | ﹤0.01% | 3758 |
|
|
2023
Q2 | $438K | Hold |
17,144
| – | – | ﹤0.01% | 3695 |
|
|
2023
Q1 | $365K | Hold |
17,144
| – | – | ﹤0.01% | 3776 |
|
|
2022
Q4 | $507K | Sell |
17,144
-4,276
| -20% | -$126K | ﹤0.01% | 3652 |
|
|
2022
Q3 | $498K | Buy |
21,420
+10,287
| +92% | +$239K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $186K | Hold |
11,133
| – | – | ﹤0.01% | 4308 |
|
|
2022
Q1 | $488K | Buy |
11,133
+1,253
| +13% | +$54.9K | ﹤0.01% | 3944 |
|
|
2021
Q4 | $601K | Hold |
9,880
| – | – | ﹤0.01% | 3947 |
|
|
2021
Q3 | $410K | Buy |
9,880
+2,401
| +32% | +$99.6K | ﹤0.01% | 4126 |
|
|
2021
Q2 | $227K | Buy |
+7,479
| New | +$227K | ﹤0.01% | 4293 |
|